citalopram and n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine

citalopram has been researched along with n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marona-Lewicka, D; Nichols, DE1
Kovar, KA; Lebsanft, HB; Mayerhofer, A; Schmidt, WJ1

Other Studies

2 other study(ies) available for citalopram and n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine

ArticleYear
Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
    Psychopharmacology, 1998, Volume: 138, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents, Second-Generation; Citalopram; Conditioning, Operant; Discrimination, Psychological; Fluoxetine; Indans; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists

1998
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
    Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:7

    Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Animals; Apomorphine; Behavior, Animal; Citalopram; Dopamine; Fenclonine; Functional Laterality; Hallucinogens; Male; Medial Forebrain Bundle; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotation; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists

2003